Skip to main content
Clinical Trials/KCT0001225
KCT0001225
Active, not recruiting
未知

The clinical study for the evaluation of the efficacy and safety of YY-312 on reducing body weight and body fat mass of obese Korean. : a 12 weeks, randomized, double-blind, placebo-controlled clinical trial

Yuyu Phama0 sites60 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Endocrine, nutritional and metabolic disease
Sponsor
Yuyu Phama
Enrollment
60
Status
Active, not recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Yuyu Phama

Eligibility Criteria

Inclusion Criteria

  • 1\) Male and female subjects between 19\-60years of age inclusive.
  • 2\) BMI of 25\.0 \- 30\.0kg/m2
  • 3\) Evidense of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the trial

Exclusion Criteria

  • 1\) Subjects with systolicBP \= 160 mmHg or diastolicBP \= 100 mmHg and also taking a beta blocker or a hydragogue
  • 2\) Subjects with diabetes(use of hypoglycemic agent or insulin)or fasting blood glucose \= 126 mg/dL or random blood glucose \= 200 mg/dL
  • 3\) Subjects with endocrinopathy or abnormal screening TSH(Thyroid\-Stimulating Hormone) value(\=0\.1uU/ml or \=10 uU/ml)
  • 4\) Subjects with hyperlipidemia) (fasting triglycerides \> 600mg/dl)
  • 5\) Serum AST(aminotransferse)/ALT(alanine amintransferse) \= 3 times the upper limit of normal
  • 6\) Serum creatinine \= 1\.5 times the upper limit of normal
  • 7\) Use of prescription drugs or supplements known to alter body weight or appetite, antidepressants, oral contraceptive, steroid, female sex hormon
  • 8\) Subjects with taking drugs that can affect the body weight within the 3 months
  • 9\) Subjects with clinically significant cardiovascular disease within the 6 months prior to screening
  • 10\) Subjects who change weight more than 4kg within 4 months

Outcomes

Primary Outcomes

Not specified

Similar Trials